21. Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study). (May 2023) Authors: Nakamura, Atsushi; Yamaguchi, Ou; Mori, Keita; Miura, Keita; Tamiya, Motohiro; Oba, Tomohiro; Yanagitani, Noriko; Mizutani, Hideaki; Ninomiya, Takashi; Kajiwara, Tomosue; Ito, Kentaro; Miyanaga, Akihiko; Arai, Daisuke; Kodama, Hiroaki; Kobayashi, Kunihiko; Kaira, Kyoichi Journal: European journal of cancer Issue: Volume 184(2023) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer. Issue 3 (13th January 2020) Authors: Takahashi, Ken; Seto, Yosuke; Okada, Koutaroh; Uematsu, Shinya; Uchibori, Ken; Tsukahara, Mika; Oh‐hara, Tomoko; Fujita, Naoya; Yanagitani, Noriko; Nishio, Makoto; Okubo, Kenichi; Katayama, Ryohei Journal: Thoracic cancer Issue: Volume 11:Issue 3(2020) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma. (19th August 2020) Authors: Okuma, Yusuke; Goto, Yasushi; Ohyanagi, Fumiyoshi; Sunami, Kuniko; Nakahara, Yoshiro; Kitazono, Satoru; Kudo, Keita; Tambo, Yuichi; Kanda, Shintaro; Yanagitani, Noriko; Horiike, Atsushi; Horinouchi, Hidehito; Fujiwara, Yutaka; Nokihara, Hiroshi; Yamamoto, Noboru; Nishio, Makoto; Ohe, Yuichiro; Ho... Journal: Cancer medicine Issue: Volume 9:Number 20(2020) Page Start: 7418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma. (19th August 2020) Authors: Okuma, Yusuke; Goto, Yasushi; Ohyanagi, Fumiyoshi; Sunami, Kuniko; Nakahara, Yoshiro; Kitazono, Satoru; Kudo, Keita; Tambo, Yuichi; Kanda, Shintaro; Yanagitani, Noriko; Horiike, Atsushi; Horinouchi, Hidehito; Fujiwara, Yutaka; Nokihara, Hiroshi; Yamamoto, Noboru; Nishio, Makoto; Ohe, Yuichiro; Ho... Journal: Cancer medicine Issue: Volume 9:Number 20(2020) Page Start: 7418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Plasma homocysteine levels and hematological toxicity in NSCLC patients after the first cycle of pemetrexed under folate supplementation. Issue 5 (June 2015) Authors: Tanaka, Hisashi; Horiike, Atsushi; Sakatani, Toshio; Saito, Ryota; Yanagitani, Noriko; Kudo, Keita; Ohyanagi, Fumiyoshi; Horai, Takeshi; Nishio, Makoto Journal: Anti-cancer drugs Issue: Volume 26:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Plasma homocysteine levels and hematological toxicity in NSCLC patients after the first cycle of pemetrexed under folate supplementation. Issue 5 (June 2015) Authors: Tanaka, Hisashi; Horiike, Atsushi; Sakatani, Toshio; Saito, Ryota; Yanagitani, Noriko; Kudo, Keita; Ohyanagi, Fumiyoshi; Horai, Takeshi; Nishio, Makoto Journal: Anti-cancer drugs Issue: Volume 26:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases. Issue 9 (12th July 2020) Authors: Tozuka, Takehiro; Kitazono, Satoru; Sakamoto, Hiroaki; Yoshida, Hiroshi; Amino, Yoshiaki; Uematsu, Shinya; Yoshizawa, Takahiro; Hasegawa, Tsukasa; Ariyasu, Ryo; Uchibori, Ken; Yanagitani, Noriko; Horai, Takeshi; Seike, Masahiro; Gemma, Akihiko; Nishio, Makoto Journal: Thoracic cancer Issue: Volume 11:Issue 9(2020) Page Start: 2465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Prognostic value of 18F‐fluoroazomycin arabinoside PET/CT in patients with advanced non‐small‐cell lung cancer. Issue 11 (7th October 2015) Authors: Saga, Tsuneo; Inubushi, Masayuki; Koizumi, Mitsuru; Yoshikawa, Kyosan; Zhang, Ming‐Rong; Tanimoto, Katsuyuki; Horiike, Atsushi; Yanagitani, Noriko; Ohyanagi, Fumiyoshi; Nishio, Makoto Journal: Cancer science Issue: Volume 106:Issue 11(2015:Nov.) Page Start: 1554 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer. (March 2016) Authors: Horiike, Atsushi; Takeuchi, Kengo; Uenami, Takeshi; Kawano, Yuko; Tanimoto, Azusa; Kaburaki, Kyohei; Tambo, Yuichi; Kudo, Keita; Yanagitani, Noriko; Ohyanagi, Fumiyoshi; Motoi, Noriko; Ishikawa, Yuichi; Horai, Takeshi; Nishio, Makoto Journal: Lung cancer Issue: Volume 93(2016) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer. (March 2016) Authors: Horiike, Atsushi; Takeuchi, Kengo; Uenami, Takeshi; Kawano, Yuko; Tanimoto, Azusa; Kaburaki, Kyohei; Tambo, Yuichi; Kudo, Keita; Yanagitani, Noriko; Ohyanagi, Fumiyoshi; Motoi, Noriko; Ishikawa, Yuichi; Horai, Takeshi; Nishio, Makoto Journal: Lung cancer Issue: Volume 93(2016) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗